The New York Times – Business:
Interim results from clinical trials suggested that Covaxin could be safe and effective, potentially removing one hurdle to New Delhi’s ambitious campaign to inoculate a vast population.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.